UK markets closed

BioLargo, Inc. (BLGO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3175-0.0095 (-2.91%)
At close: 03:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 96.78M
Enterprise value 94.12M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.14
Price/book (mrq)11.93
Enterprise value/revenue 7.10
Enterprise value/EBITDA -10.33

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 373.68%
S&P500 52-week change 326.36%
52-week high 30.4500
52-week low 30.1500
50-day moving average 30.3402
200-day moving average 30.2298

Share statistics

Avg vol (3-month) 3413.91k
Avg vol (10-day) 3226.7k
Shares outstanding 5295.97M
Implied shares outstanding 6308.18M
Float 8253.7M
% held by insiders 114.19%
% held by institutions 10.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 428 May 1997
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -27.68%
Operating margin (ttm)-16.03%

Management effectiveness

Return on assets (ttm)-34.04%
Return on equity (ttm)-113.31%

Income statement

Revenue (ttm)13.25M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)27.20%
Gross profit (ttm)N/A
EBITDA -4.37M
Net income avi to common (ttm)-3.67M
Diluted EPS (ttm)-0.0200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.34M
Total cash per share (mrq)0.01
Total debt (mrq)1.67M
Total debt/equity (mrq)32.52%
Current ratio (mrq)2.11
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-1.84M
Levered free cash flow (ttm)-1.17M